BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28569257)

  • 1. Current status and future prospect of FSHD region gene 1.
    Hansda AK; Tiwari A; Dixit M
    J Biosci; 2017 Jun; 42(2):345-353. PubMed ID: 28569257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
    Hanel ML; Sun CY; Jones TI; Long SW; Zanotti S; Milner D; Jones PL
    Differentiation; 2011 Feb; 81(2):107-18. PubMed ID: 20970242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscular dystrophy candidate gene FRG1 is critical for muscle development.
    Hanel ML; Wuebbles RD; Jones PL
    Dev Dyn; 2009 Jun; 238(6):1502-12. PubMed ID: 19097195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the effects of FSHD candidate gene expression in vertebrate muscle development.
    Wuebbles RD; Long SW; Hanel ML; Jones PL
    Int J Clin Exp Pathol; 2010 Mar; 3(4):386-400. PubMed ID: 20490329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.
    Liu Q; Jones TI; Tang VW; Brieher WM; Jones PL
    J Cell Sci; 2010 Apr; 123(Pt 7):1116-23. PubMed ID: 20215405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
    Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
    PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
    Wuebbles RD; Hanel ML; Jones PL
    Dis Model Mech; 2009; 2(5-6):267-74. PubMed ID: 19383939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).
    Pistoni M; Shiue L; Cline MS; Bortolanza S; Neguembor MV; Xynos A; Ares M; Gabellini D
    PLoS Genet; 2013; 9(1):e1003186. PubMed ID: 23300487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.
    Sun CY; van Koningsbruggen S; Long SW; Straasheijm K; Klooster R; Jones TI; Bellini M; Levesque L; Brieher WM; van der Maarel SM; Jones PL
    J Mol Biol; 2011 Aug; 411(2):397-416. PubMed ID: 21699900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.
    Bortolanza S; Nonis A; Sanvito F; Maciotta S; Sitia G; Wei J; Torrente Y; Di Serio C; Chamberlain JR; Gabellini D
    Mol Ther; 2011 Nov; 19(11):2055-64. PubMed ID: 21829175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.
    Pirozhkova I; Petrov A; Dmitriev P; Laoudj D; Lipinski M; Vassetzky Y
    PLoS One; 2008; 3(10):e3389. PubMed ID: 18852887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35.
    van Deutekom JC; Lemmers RJ; Grewal PK; van Geel M; Romberg S; Dauwerse HG; Wright TJ; Padberg GW; Hofker MH; Hewitt JE; Frants RR
    Hum Mol Genet; 1996 May; 5(5):581-90. PubMed ID: 8733123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis.
    Neguembor MV; Xynos A; Onorati MC; Caccia R; Bortolanza S; Godio C; Pistoni M; Corona DF; Schotta G; Gabellini D
    J Mol Cell Biol; 2013 Oct; 5(5):294-307. PubMed ID: 23720823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased FSHD region gene1 expression reduces
    Tiwari A; Pattnaik N; Mohanty Jaiswal A; Dixit M
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28947680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FRG1P-mediated aggregation of proteins involved in pre-mRNA processing.
    van Koningsbruggen S; Straasheijm KR; Sterrenburg E; de Graaf N; Dauwerse HG; Frants RR; van der Maarel SM
    Chromosoma; 2007 Feb; 116(1):53-64. PubMed ID: 17103222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM; Pakula A; Lek A; Emerson CP
    Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.
    D'Antona G; Brocca L; Pansarasa O; Rinaldi C; Tupler R; Bottinelli R
    J Physiol; 2007 Nov; 584(Pt 3):997-1009. PubMed ID: 17855756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.